IVOR ROYSTON - 08 Jul 2022 Form 4 Insider Report for BIOCEPT INC (BIOC)

Role
Director
Signature
/s/ Darrell Taylor, Attorney-in-fact
Issuer symbol
BIOC
Transactions as of
08 Jul 2022
Net transactions value
$0
Form type
4
Filing time
08 Sep 2022, 14:32:49 UTC
Previous filing
27 May 2022
Next filing
29 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOC Employee Stock Option (right to buy) Award $0 +10,000 $0.000000 10,000 08 Jul 2022 Common Stock 10,000 $1.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall be 100% vested and exercisable on July 8, 2023.